Almost no CTLA-4 expressing T cells were observed in PBMC HC (0.2 ± 0.1%), which was significantly lower than the percentage detected in PBMC HNSCC (2.0 ± 2.1%, p < 0.005). The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.